X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.biospectrumasia.com/news/25/24109/korean-firm-hyundai-bioscience-soon-to-initiate-global-clinical-development-on-dengue-antiviral-candidate.html
https://www.prnewswire.com/news-releases/hyundai-bioscience-announces-that-xafty-is-the-only-antiviral-that-can-be-immediately-used-for-the-treatment-of-dengue-fever-301955962.html
https://www.prnewswire.com/news-releases/hyundai-bioscience-announced-positive-phase-2-clinical-study-results-of-the-global-blockbuster-candidate-for-the-covid-19-antiviral-drug-301814076.html
https://www.prnewswire.com/news-releases/chemotherapy-may-be-completed-within-8-days-with-two-doses-of-polytaxel-an-innovative-anticancer-drug-from-south-koreas-biotech-firm-301687078.html
https://www.pharmaceutical-technology.com/news/hyundai-monkeypox-drug-fda/
https://www.clinicaltrialsarena.com/news/hyundai-bioscience-trial-covid-19-drug/
https://www.pharmaceutical-technology.com/news/hyundai-combination-therapy-covid/
Market Place
Share 
